|
|
|
Structural Bioinformatics Get one review (Villoutreix, Curr Prot Pep Science 2002) here
Structural and
theoretical analyses of proteins are central to
the understanding of complex molecular mechanisms and are fundamental
to the
drug discovery process. Computational techniques yield useful insights
into an
ever-wider range of biomolecular systems. Protein three-dimensional
structures
and molecular functions can be predicted in some circumstances, while
experimental structures can be analyzed in depth via such computational
approaches. Non-covalent binding of biomolecules can be understood by
considering structural, thermodynamic and kinetic issues, and
theoretical
simulations of such events can be attempted. The central role of
electrostatic
interactions with regard to protein function, structure and stability
has been
investigated and some electrostatic properties can be modeled
theoretically.
Computer methods thus help to prioritize, design, analyze and
rationalize
biochemical experiments. For instance, we have been using protein docking to investigate the tenase and prothrombinase complexes. You can see Autin L et a., Proteins, 2006, 63:440-50 (PDF here) and Autin L et al., J Thromb Haemost. 2005, 3:2044-56 (here). For MD simulations, investigation of point mutations and electrostatic computations, you can see Miteva M. et al., Nucleic Acids Res. 2005, 33: W372-5 (here) and Miteva M. et al., Biophys J. 2004, 86:488-98 (here)
|
|
Virtual Ligand Screening
Get
one review (Sperandio, Miteva, Delfaud, Villoutreix, Curr Prot Pep Science 2006) here
Get
another review (Villoutreix, Renault, Lagorce, Sperandio, Montes, Miteva, Curr Prot Pep Science 2007) here
In today's research
environment, a
wealth of experimental structural data are available and the number of
therapeutically relevant macromolecular structures is growing rapidly.
This,
coupled with the huge amount of small non-peptide potential drug
candidates on
hand highlight the need of using computer-aided techniques for the
efficient identification and optimization of novel hit compounds.
Virtual (or in silico)
ligand screening based on the three-dimensional structure of
macromolecular
targets (SB-VLS) is firmly established as an important approach to
identify
chemical entities that have a high likelihood of binding to a target
molecule
to elicit desired biological responses. When the 3D structure of the
receptor
is not known, it is possible to use in some cases ligand-based in
silico
screening methods.
Combining VLS and experimental HTS You can see some recent studies from our group for ADME/tox, Miteva et al., 2006, Nucleic Acids Res. 2006, 34:W738-44 (here) and for VLS, Miteva et al., J Med Chem. 2005, 48:6012-22 (here). |